Amedeo Smart

Free Medical Literature Service


 

Amedeo

Head and Neck Cancer

  Free Subscription

Articles published in
Cancer
    December 2024
  1. NIERENGARTEN MB
    First person profile: Quynh-Thu Le, MD: Dr Le confronts the difficult challenges of improving the efficacy and safety of radiation therapy in the treatment of head and neck cancers.
    Cancer. 2024;130:4164.
    >> Share

  2. ABYANEH R, Ghalehtaki R, Sanford NN
    Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review.
    Cancer. 2024;130:4040-4051.
    >> Share

  3. NIERENGARTEN MB
    Promising long-term disease control and survival with pembrolizumab and cabozantinib for head and neck cancer.
    Cancer. 2024;130:3947.
    >> Share

  4. NIERENGARTEN MB
    Increased head and neck cancer linked to cannabis use.
    Cancer. 2024;130:3946.
    >> Share

    November 2024
  5. DAY AT, Mitchell DN, Eary RL, Jones E, et al
    Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors.
    Cancer. 2024 Nov 26. doi: 10.1002/cncr.35639.
    >> Share

  6. BERZENJI D, Oude Booijink ORG, Gahrmann R, Mast H, et al
    A comprehensive approach to defining the cutoff value of oligometastasis in head and neck squamous cell carcinoma.
    Cancer. 2024 Nov 5. doi: 10.1002/cncr.35632.
    >> Share

    August 2024
  7. WU Q, Hu C, Feng L, Yang X, et al
    Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma.
    Cancer. 2024 Aug 14. doi: 10.1002/cncr.35517.
    >> Share

    July 2024
  8. SALZ T, Meza AM, Bradshaw PT, Jinna S, et al
    Role of primary care in opioid prescribing for older head and neck cancer survivors.
    Cancer. 2024 Jul 27. doi: 10.1002/cncr.35478.
    >> Share

  9. GOODMAN KA, Hotca A, Liu M, Strong VE, et al
    Top advances of the year: Gastroesophageal cancer.
    Cancer. 2024;130:2253-2256.
    >> Share

    June 2024
  10. NIERENGARTEN MB
    First person profile: Everett Vokes, MD: Pioneer of the combination of radiation and chemotherapy as the first line of treatment for head and neck cancer.
    Cancer. 2024;130:2082-2083.
    >> Share

  11. NIERENGARTEN MB
    FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
    Cancer. 2024;130:1903.
    >> Share

    May 2024
  12. NING T, Li D, Deng T, Bai Y, et al
    Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
    Cancer. 2024 May 23. doi: 10.1002/cncr.35377.
    >> Share

  13. NIERENGARTEN MB
    First person profile: Barbara Burtness, MD: For more than 20 years, she has applied advances in molecular biology to better treat patients with head and neck cancers.
    Cancer. 2024;130:1724.
    >> Share

    March 2024
  14. HO AL, Foster NR, Deraje Vasudeva S, Katabi N, et al
    A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
    Cancer. 2024;130:702-712.
    >> Share

    February 2024
  15. CHOI H, Cho SW, Kim HH, Yi KH, et al
    Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma.
    Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256.
    >> Share

  16. DE ALMEIDA JR, Su JS, Kolarski MM, Truong T, et al
    Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma.
    Cancer. 2024;130:410-420.
    >> Share

    January 2024
  17. GROSS ND, Seiwert TY
    Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
    Cancer. 2024 Jan 18. doi: 10.1002/cncr.35198.
    >> Share

  18. NIERENGARTEN MB
    Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer.
    Cancer. 2024;130:172.
    >> Share

  19. NIERENGARTEN MB
    Oral health linked to survival in head and neck cancer.
    Cancer. 2024;130:171.
    >> Share

    December 2023

  20. Researchers identify two new subtypes of HPV-associated head and neck cancers.
    Cancer. 2023;129:3842.
    >> Share

    October 2023
  21. CARPENTER DJ, Patel P, Niedzwiecki D, Dillon M, et al
    Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancer.
    Cancer. 2023 Oct 28. doi: 10.1002/cncr.35089.
    >> Share

  22. MORAND GB, Eskander A, Fu R, de Almeida J, et al
    The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative.
    Cancer. 2023;129:3263-3274.
    >> Share

  23. PHILIPS R, Alnemri A, Amin D, Patel J, et al
    Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
    Cancer. 2023 Oct 3. doi: 10.1002/cncr.35045.
    >> Share

    September 2023
  24. ZHANG L, San Valentin EMD, John TM, Jenq RR, et al
    Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2023 Sep 8. doi: 10.1002/cncr.35001.
    >> Share

    July 2023
  25. PATEL SA, Gibson MK, Deal A, Sheth S, et al
    A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.
    Cancer. 2023 Jul 3. doi: 10.1002/cncr.34930.
    >> Share

    May 2023
  26. FAN JH, Sun WY, Yang H, Wang XK, et al
    Short-term and long-term effect of nutrition intervention in the Linxian Dysplasia Nutrition Intervention Trial and the reason for disappearance of the intervention effect: A cohort study.
    Cancer. 2023 May 27. doi: 10.1002/cncr.34761.
    >> Share

  27. HARING CT, Kana LA, Dermody SM, Brummel C, et al
    Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Cancer. 2023 May 10. doi: 10.1002/cncr.34823.
    >> Share


  28. Erratum to "Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma".
    Cancer. 2023 May 2. doi: 10.1002/cncr.34829.
    >> Share

  29. RAMKUMAR SP, Simpson MC, Adjei Boakye E, Bukatko AR, et al
    High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
    Cancer. 2023;129:1372-1383.
    >> Share

    April 2023
  30. YAN L, Li Y, Li XY, Xiao J, et al
    Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Cancer. 2023 Apr 15. doi: 10.1002/cncr.34802.
    >> Share

  31. D'SOUZA G, Tewari SR, Troy T, Waterboer T, et al
    Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    Cancer. 2023 Apr 9. doi: 10.1002/cncr.34783.
    >> Share

    March 2023
  32. WILLIAM WN JR, Zhang J, Zhao X, Parra ER, et al
    Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
    Cancer. 2023;129:714-727.
    >> Share

    February 2023
  33. OH DY, Algazi A, Capdevila J, Longo F, et al
    Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
    Cancer. 2023 Feb 7. doi: 10.1002/cncr.34657.
    >> Share

  34. QUAN DL, Grauer JS, Sunkara PR, Cramer JD, et al
    Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
    Cancer. 2023;129:376-384.
    >> Share

    January 2023
  35. VERMA A, Burtness B
    Top advances of the year: Head and neck cancer.
    Cancer. 2023 Jan 24. doi: 10.1002/cncr.34654.
    >> Share

  36. LEE JJW, Kunaratnam V, Kim CJH, Pienkowski M, et al
    Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
    Cancer. 2023 Jan 18. doi: 10.1002/cncr.34620.
    >> Share

    November 2022
  37. KOYUNCU CF, Nag R, Lu C, Corredor G, et al
    Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2022;128:3831-3842.
    >> Share

    October 2022
  38. BROSE MS, Robinson BG, Sherman SI, Jarzab B, et al
    Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
    Cancer. 2022 Oct 19. doi: 10.1002/cncr.34493.
    >> Share

  39. JACKSON SS, Marks MA, Katki HA, Cook MB, et al
    Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors.
    Cancer. 2022;128:3531-3540.
    >> Share


  40. Sharp rise in esophageal cancer and Barrett esophagus seen in middle-aged people.
    Cancer. 2022;128:3584-3585.
    >> Share

    August 2022
  41. LIN Y, Bruner DW, Paul S, Miller AH, et al
    A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy.
    Cancer. 2022 Aug 15. doi: 10.1002/cncr.34424.
    >> Share

    July 2022
  42. MAZUL AL, Hartman CM, Mowery YM, Kramer JR, et al
    Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Cancer. 2022 Jul 22. doi: 10.1002/cncr.34387.
    >> Share

  43. HSUEH CY, Lau HC, Huang Q, Gong H, et al
    Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2022 Jul 5. doi: 10.1002/cncr.34338.
    >> Share

    June 2022

  44. Erratum to "Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study".
    Cancer. 2022 Jun 24. doi: 10.1002/cncr.34358.
    >> Share

  45. FAN JH, Wang JB, Yang H, Dawsey SM, et al
    Mortality after multivitamin supplementation: Nearly 35-year follow-up of the randomized Linxian Dysplasia Nutrition Intervention Trial.
    Cancer. 2022 Jun 7. doi: 10.1002/cncr.34344.
    >> Share

  46. O'BOYLE CJ, Siravegna G, Varmeh S, Queenan N, et al
    Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2022;128:2193-2204.
    >> Share

    May 2022
  47. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
    Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
    >> Share

  48. NELSON TJ, Thompson CA, Zou J, Kumar A, et al
    Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database.
    Cancer. 2022;128:1948-1957.
    >> Share

  49. COWZER D, Janjigian YY
    Top advances in esophageal/gastroesophageal junction cancers in 2021.
    Cancer. 2022;128:1894-1899.
    >> Share

  50. LI Y, Yao F, Jiao Z, Su X, et al
    Cyclin-dependent kinase 5 promotes the growth of tongue squamous cell carcinoma through the microRNA 513c-5p/cell division cycle 25B pathway and is associated with a poor prognosis.
    Cancer. 2022;128:1775-1786.
    >> Share

    April 2022
  51. KIYOTA N, Tahara M, Robinson B, Schlumberger M, et al
    Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial.
    Cancer. 2022 Apr 5. doi: 10.1002/cncr.34181.
    >> Share

  52. HUTCHESON KA, Barbon CEA, Alvarez CP, Warneke CL, et al
    Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2.
    Cancer. 2022;128:1458-1466.
    >> Share

    March 2022
  53. PARK S, Oh D, Choi YL, Chi SA, et al
    Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Cancer. 2022 Mar 23. doi: 10.1002/cncr.34176.
    >> Share

  54. SOO J, Jin MC, Beadle BM, Holsinger FC, et al
    Circulating tumor DNA in head and neck cancer: Early successes and future promise.
    Cancer. 2022 Mar 17. doi: 10.1002/cncr.34189.
    >> Share

  55. CHUNG HC, Kang YK, Chen Z, Bai Y, et al
    Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
    Cancer. 2022;128:995-1003.
    >> Share

    February 2022
  56. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    >> Share

  57. OLIVER JR, Persky MJ, Wang B, Duvvuri U, et al
    Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.
    Cancer. 2022;128:685-696.
    >> Share

  58. SCOTT-WITTENBORN N, D'Souza G, Tewari S, Rooper L, et al
    Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34124.
    >> Share

  59. SOUSA LG, Wang K, Torman D, Binks BJ, et al
    Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified.
    Cancer. 2022;128:509-518.
    >> Share

    January 2022
  60. BALACHANDRA S, Eary RL, Lee R, Wynings EM, et al
    Substance use and mental health burden in head and neck and other cancer survivors: A National Health Interview Survey analysis.
    Cancer. 2022;128:112-121.
    >> Share

    December 2021
  61. LIANG L, Liu Z, Zhu H, Wang H, et al
    Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Cancer. 2021 Dec 15. doi: 10.1002/cncr.34074.
    >> Share

  62. WOTMAN MT, Miles BA, Bakst RL, Posner MR, et al
    A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2021;127:4330-4338.
    >> Share

  63. AGGARWAL P, Hutcheson KA, Garden AS, Mott FE, et al
    Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
    Cancer. 2021;127:4470-4480.
    >> Share

    October 2021
  64. TREISTER NS, Brennan MT, Sollecito TP, Schmidt BL, et al
    Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
    Cancer. 2021 Oct 19. doi: 10.1002/cncr.33948.
    >> Share

  65. REN J, Pang W, Hueniken K, Haddad G, et al
    Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33936.
    >> Share

  66. FAKHRY C, Tewari SR, Zhang L, Windon MJ, et al
    RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
    Cancer. 2021;127:3523-3530.
    >> Share

    September 2021
  67. FOSTER CC, Couey MA, Kochanny SE, Khattri A, et al
    Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors.
    Cancer. 2021 Sep 21. doi: 10.1002/cncr.33780.
    >> Share

  68. ABDELMEGUID AS, Hanna EY
    Reply to Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3265.
    >> Share

  69. PANDA S, Raveendran S, Kumar R, Thakar A, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3264.
    >> Share

  70. WU J, Xiao F, Zheng Y, Lin Y, et al
    Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Cancer. 2021;127:3172-3182.
    >> Share

  71. RYAN WR, Xu MJ, Ochoa E, Plonowska-Hirschfeld KA, et al
    Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
    Cancer. 2021;127:3092-3106.
    >> Share

  72. ABDELMEGUID AS, Silver NL, Boonsripitayanon M, Glisson BS, et al
    Role of induction chemotherapy for oral cavity squamous cell carcinoma.
    Cancer. 2021;127:3107-3112.
    >> Share

    August 2021
  73. SEAMAN AT, Seligman KL, Nguyen KK, Al-Qurayshi Z, et al
    Characterizing head and neck cancer survivors' discontinuation of survivorship care.
    Cancer. 2021 Aug 30. doi: 10.1002/cncr.33888.
    >> Share

  74. HARDMAN JC, Tikka T, Paleri V
    Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
    Cancer. 2021 Aug 19. doi: 10.1002/cncr.33800.
    >> Share

  75. GUO TW, Saiyed F, Yao CMKL, Kiong KL, et al
    Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
    Cancer. 2021;127:2916-2925.
    >> Share

  76. CHERA BS, Sheth SH, Patel SA, Goldin D, et al
    Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33789.
    >> Share

  77. AMIT M, Liu C, Mansour J, Gleber-Netto FO, et al
    Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33773.
    >> Share

  78. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    >> Share

    July 2021
  79. YU KJ, Hsu WL, Chiang CJ, Chen TC, et al
    Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33799.
    >> Share

  80. ROMESSER PB, Sherman EJ, Whiting K, Ho ML, et al
    Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial.
    Cancer. 2021 Jul 22. doi: 10.1002/cncr.33804.
    >> Share

  81. VAN DIJK LV, Mohamed ASR, Ferrarotto R, McCoy LA, et al
    The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
    Cancer. 2021;127:2453-2464.
    >> Share

  82. WHITMARSH A, Pring M, Thomas SJ, Waylen A, et al
    Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Cancer. 2021;127:2442-2452.
    >> Share

  83. XIAO Q, Kitahara CM
    Reply to associations between light at night and risk of thyroid cancer.
    Cancer. 2021 Jul 10. doi: 10.1002/cncr.33685.
    >> Share

  84. XIAO P, Li L, Ding S, Xie J, et al
    Associations between light at night and risk of thyroid cancer.
    Cancer. 2021 Jul 10. doi: 10.1002/cncr.33686.
    >> Share

  85. LIU Z, Li H, Yu KJ, Xie SH, et al
    Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma.
    Cancer. 2021 Jul 7. doi: 10.1002/cncr.33552.
    >> Share

    June 2021
  86. FU TS, Scheffler P, Forner D, Noel CW, et al
    A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33653.
    >> Share

  87. SABA NF
    Preoperative chemotherapy for sinonasal squamous cell carcinoma (SNSCC): Time to move closer to a definitive answer.
    Cancer. 2021;127:1734-1735.
    >> Share

  88. ABDELMEGUID AS, Teeramatwanich W, Roberts DB, Amit M, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
    Cancer. 2021;127:1788-1795.
    >> Share

    May 2021
  89. RUAN X, Liang JH, Pan Y, Cai R, et al
    Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 study.
    Cancer. 2021 May 27. doi: 10.1002/cncr.33626.
    >> Share

  90. XIAO C, Beitler JJ, Peng G, Levine ME, et al
    Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
    Cancer. 2021 May 24. doi: 10.1002/cncr.33641.
    >> Share

  91. JUNG YS, Seok J, Hong S, Ryu CH, et al
    The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population.
    Cancer. 2021;127:1638-1647.
    >> Share

  92. SHANMUGAM A, Hariharan AK, Hasina R, Nair JR, et al
    Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma.
    Cancer. 2021;127:1576-1589.
    >> Share

  93. WEISS JM
    Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-Can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m(2) ?
    Cancer. 2021 May 6. doi: 10.1002/cncr.33610.
    >> Share

    April 2021
  94. DAHLSTROM KR, Song J, Thall PF, Fuller CD, et al
    Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
    Cancer. 2021;127:1228-1237.
    >> Share

  95. CHEN Y, Chang ET, Liu Q, Cai Y, et al
    Occupational exposures and risk of nasopharyngeal carcinoma in a high-risk area: A population-based case-control study.
    Cancer. 2021 Apr 6. doi: 10.1002/cncr.33536.
    >> Share

  96. THOMAS GR
    Racial disparity in head and neck cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33555.
    >> Share

  97. VOORA RS, Kotha NV, Kumar A, Qiao EM, et al
    Association of Race and Health Care System With Disease Stage and Survival in Veterans With Larynx Cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33557.
    >> Share

  98. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    >> Share

    March 2021
  99. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    >> Share

    February 2021
  100. HO AS, Luu M, Kim S, Tighiouart M, et al
    Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33414.
    >> Share

  101. CAMPBELL BR, Chen Z, Faden DL, Agrawal N, et al
    The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
    Cancer. 2021;127:544-553.
    >> Share

  102. ZHANG D, Jones RR, James P, Kitahara CM, et al
    Associations between artificial light at night and risk for thyroid cancer: A large US cohort study.
    Cancer. 2021 Feb 8. doi: 10.1002/cncr.33392.
    >> Share

  103. YIP L, Gooding WE, Nikitski A, Wald AI, et al
    Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study.
    Cancer. 2021 Feb 4. doi: 10.1002/cncr.33421.
    >> Share

  104. STRACHNA O, Cohen MA, Allison MM, Pfister DG, et al
    Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities.
    Cancer. 2021;127:359-371.
    >> Share

    January 2021
  105. ALHUMAIDI H, Manochakian R, Cochuyt J, Chindris A, et al
    Initial treatment of patients with thyroid cancer: Outcomes and factors associated with care at academic versus nonacademic cancer centers.
    Cancer. 2021 Jan 15. doi: 10.1002/cncr.33408.
    >> Share

    June 2020
  106. BROUGHMAN JR, Xiong DD, Moeller BJ, Contrera KJ, et al
    Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
    Cancer. 2020;126:2784-2790.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016